Moody’s affirms ‘Baa3’ rating for OU Medicine

 
Moody’s Investors Service affirmed its “Baa3” rating for Oklahoma City-based OU Medicine, affecting $1.2 billion of debt.

Advertisement

The affirmation reflects the system’s prominence as a large provider of high acuity services in the Oklahoma City area which will support strong demand and a good market position. The expansion of pediatric and adult beds over the next few years will allow the system to grow.

The rating outlook is stable.

More articles on healthcare finance:

Kansas community hospital clears hurdle to get sales tax help
How Novant Health alerts patients of split billing
Genesis HealthCare posts $6.9M net loss for 2018

Advertisement

Next Up in Financial Management

Advertisement

Comments are closed.